Cargando…
Gigantol inhibits cell proliferation and induces apoptosis by regulating DEK in non-small cell lung cancer
Non-small cell lung cancer (NSCLC) is a common type of cancer, with a mortality of >80% worldwide. Gigantol is a bibenzyl compound that displays anticancer activity. The aim of the present study was to determine the biological activity of gigantol in NSCLC and to elucidate the underlying molecula...
Autores principales: | Cai, Yuxing, Hao, Yi, Xu, Hui, Chen, Kai, Ren, Baozhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495587/ https://www.ncbi.nlm.nih.gov/pubmed/34630671 http://dx.doi.org/10.3892/etm.2021.10752 |
Ejemplares similares
-
Gigantol Inhibits Epithelial to Mesenchymal Process in Human Lung Cancer Cells
por: Unahabhokha, Thitita, et al.
Publicado: (2016) -
Gigantol Suppresses Cancer Stem Cell-Like Phenotypes in Lung Cancer Cells
por: Bhummaphan, Narumol, et al.
Publicado: (2015) -
MiR-138-5p Inhibits the Proliferation of Gastric Cancer Cells by Targeting DEK
por: Zhang, Wei, et al.
Publicado: (2020) -
Gigantol inhibits Wnt/β-catenin signaling and exhibits anticancer activity in breast cancer cells
por: Yu, Shubin, et al.
Publicado: (2018) -
Gigantol Improves Cholesterol Metabolism and Progesterone Biosynthesis in MA-10 Leydig Cells
por: Basque, Audrey, et al.
Publicado: (2021)